<u>Annualized</u> 4Q07 Copaxone sales by region (as reported by Teva): US: <b>$1.08B</b> (62% of total), +13% YoY, -4% QoQ ex-US: $664M (38% of total), +19% YoY, +4% QoQ === Total: <b>$1.74B</b>, +15% YoY, -1% QoQ <a href="http://biz.yahoo.com/bw/080212/20080211006686.html" target="_blank">http://biz.yahoo.com/bw/080212/20080211006686.html</a>